🇺🇸 FDA
Patent

US 8933217

Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders

granted A61KA61K31/352A61K31/357

Quick answer

US patent 8933217 (Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders) held by Amazentis SA expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
52
CPC classes
A61K, A61K31/352, A61K31/357, A61K31/57, A61K31/7024